An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of golimumab, alone or in
combination with methotrexate (MTX), as compared to methotrexate alone in rheumatoid
arthritis (RA) patients who have active rheumatoid arthritis despite treatment with MTX.